Friday, March 04, 2011
Mutation deep within an intron of MSH2 causes Lynch syndrome
".......... thus highlighting the need for more extensive sequencing approaches in families where routine procedures fail to find a mutation."
| REACTIONS? |
add your opinions
exon 2
,
genetics
,
Lynch Syndrome
,
MSH2
,
mutations
,
sequencing
CHSPR - University of British Columbia: 2011 Health Policy Conference BOOMERANGST: Myths and Realities about health care for an aging population (Lewis/Berwick quote...)
Note: 1) includes influence of cancer/aging/demographics 2) referenced via Hsien Seow presentation: "Inbalance. Not by chance. (Don Berwick quote: every system is perfectly designed to produce exactly the results it gets. A systematic issue.) We have a system that provide PC only when patients are “dying” or at EOL. – actively dying." ......................................................................Day 1: February 22, 2011 |
|---|
| 8:30 am -- Welcome from the co-chairs |
| Patricia Baird, University of British Columbia | Audio | Slides |
| 9:00 am -- Opening Plenary: Myths and Realities about demographics |
| Jay Olshansky, University of Illinois | Audio | Slides | |
| Alan Cassels, University of Victoria | Audio | Slides |
| 11:00 am -- Session I: Will aging bankrupt the health care system? |
| Michael Wolfson, University of Ottawa | Audio | Slides | |
| Stephen Duckett, University of Alberta | Audio | Slides |
| 12:00 pm -- Lunch Presentation | Audio | Slides |
| 1:15 pm -- Session II: Is it possible (or sensible) to differentiate health and social care? |
| John Sloan, University of British Columbia | Audio | Slides | |
| Jon Glasby, University of Birmingham | Audio | Slides | |
| Vasanthi Srinivasan, Ontario Health Systems Strategy Division | Audio | Slides |
| 2:45 pm -- Session III: Aging in (what) place? |
| Carole Estabrooks, Canada Research Chair in Knowledge Translation | Audio | Slides | |
| Tine Rostgaard, Danish National Institute of Social Research | Audio | Slides | |
| Neena Chappell, Department of Sociology at the University of Victoria | Audio | Slides |
Day 2: February 23, 2011 |
|---|
| 8:30 am -- Session IV: Whose death is it anyway? |
| Hsien Seow, Cancer Care Ontario Research Chair | Audio | Slides | |
| Dr. Michael Dolan, Internal Medicine Physician | Audio | Slides | |
| Hon. Sharon Carstairs, P.C., Liberal Senate Forum | Audio |
| 10:30 am -- Session V: Is aging a disease? |
| Matthew Farrer, Centre for Molecular Medicine and Therapeutics | Audio | Slides | |
| Ross Upshur, University of Toronto Joint Centre for Bioethics | Audio | Slides |
| 12:00 pm -- Closing Plenary Speaker |
| Steven Lewis, Health Care Consultant, Saskatoon | Audio |
| REACTIONS? |
add your opinions
aging
,
healthcare policy
,
myths
,
realites
Cochrane review: Interventions for preventing neuropathy caused by cisplatin and related compounds
AUTHORS' CONCLUSIONS: At present, the data are insufficient to conclude that any of the purported chemoprotective agents (acetylcysteine, amifostine, calcium and magnesium, diethyldithiocarbamate, glutathione, Org 2766, oxycarbazepine, or Vitamin E) prevent or limit the neurotoxicity of platin drugs among human patients.
| REACTIONS? |
add your opinions
Amifostine
,
calcium
,
chemoprotection
,
Cisplatin
,
Glutathione peroxidase 3
,
magnesium
,
neurotoxicity
,
platinum
,
vitamin E
Subscribe to:
Posts
(
Atom
)

